Loading…

Identification of pathogenic C9orf72 hexanucleotide repeat expansion in a Chinese patient with frontotemporal dementia: A case report

The discovery that abnormal GGGGCC hexanucleotide repeat expansions (HRE) in C9orf72 was a common cause of FTD and amyotrophic lateral sclerosis (ALS) fueled and speeded up the research in C9orf72‐related ALS and FTD worldwide. 1,2 This pathogenic expansion could cause disease by loss of normal func...

Full description

Saved in:
Bibliographic Details
Published in:CNS neuroscience & therapeutics 2021-06, Vol.27 (6), p.725-727
Main Authors: Xue, Yan‐Yan, Wu, Zhi‐Ying, Li, Hong‐Fu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4109-862cc4dad9af8e23f24b8a046f5555c701c1428d24a6ff6ba73cfc9f0507d5283
cites cdi_FETCH-LOGICAL-c4109-862cc4dad9af8e23f24b8a046f5555c701c1428d24a6ff6ba73cfc9f0507d5283
container_end_page 727
container_issue 6
container_start_page 725
container_title CNS neuroscience & therapeutics
container_volume 27
creator Xue, Yan‐Yan
Wu, Zhi‐Ying
Li, Hong‐Fu
description The discovery that abnormal GGGGCC hexanucleotide repeat expansions (HRE) in C9orf72 was a common cause of FTD and amyotrophic lateral sclerosis (ALS) fueled and speeded up the research in C9orf72‐related ALS and FTD worldwide. 1,2 This pathogenic expansion could cause disease by loss of normal function of C9orf72 protein, RNA toxicity, and dipeptide‐repeat proteins aggregates. 3,4 Although the mechanisms for different phenotypes of C9orf72 HRE have not been well unveiled, the proteomic cerebrospinal fluid analyses and imaging studies provided potential biomarkers for C9orf72‐linked FTD and ALS. 5‐6 Previous studies showed the most common symptoms of C9orf72‐linked FTD were behavioral disinhibition and psychiatric disorders. 7‐9 Notably, 60% of C9orf72‐related FTD patients developed motor neuron disease symptoms during follow‐up. 9 C9orf72 HRE was the leading genetic cause of ALS and FTD in Caucasian populations, accounting for 21.7%‐47.0% in familial ALS, 13.8%‐48.1% in familial FTD, 4.1%‐21.1% in sporadic ALS, and 2.2%‐18.8% in sporadic FTD. 10,11 However, the C9orf72 HRE was rare in the Asian population, which could only explain around 0.4% ALS in Japan, 3.5% family ALS, and 0.5% sporadic ALS in Chinese populations. 12,13 The prevalence of C9orf72‐related FTD was not clear in China, which calls for a large‐scale multicenter study. The genetic investigation revealed more than 93 times repeat expansions (normal
doi_str_mv 10.1111/cns.13639
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8111495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2524656787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4109-862cc4dad9af8e23f24b8a046f5555c701c1428d24a6ff6ba73cfc9f0507d5283</originalsourceid><addsrcrecordid>eNp1kU1OHDEQhS0ECoRkwQUiS1llMeD2T7fNAgm1SIKEkgVkbXncZdpoxu7YngAH4N7xMGREFtSmSvKrr578EDpqyHFT68SGfNywlqkddNB0QsyE4mp3OzOyj97nfEdIS6WS79A-Y52UTNID9HQ5QCjeeWuKjwFHhydTxngLwVvcq5hcR_EIDyas7AJi8QPgBBOYguFhMiGvt3zABvejD5Bhve8rE9_7MmKXYiixwHKKySzwAMv1OXOKz7E1-RkVU_mA9pxZZPj40g_Rr68XN_332dXPb5f9-dXM8oaomWyptXwwgzJOAmWO8rk0hLdO1LIdaWzDqRwoN61z7dx0zDqrHBGkGwSV7BCdbbjTar6EwVYv1ZWekl-a9Kij8fr_l-BHfRv_aFm_mStRAZ9fACn-XkEu-i6uUqieNRWUt6LtZFdVXzYqm2LOCdz2QkP0OjFdE9PPiVXtp9eWtsp_EVXByUZw7xfw-DZJ9z-uN8i_4LWjeA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2524656787</pqid></control><display><type>article</type><title>Identification of pathogenic C9orf72 hexanucleotide repeat expansion in a Chinese patient with frontotemporal dementia: A case report</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>PubMed Central</source><creator>Xue, Yan‐Yan ; Wu, Zhi‐Ying ; Li, Hong‐Fu</creator><creatorcontrib>Xue, Yan‐Yan ; Wu, Zhi‐Ying ; Li, Hong‐Fu</creatorcontrib><description>The discovery that abnormal GGGGCC hexanucleotide repeat expansions (HRE) in C9orf72 was a common cause of FTD and amyotrophic lateral sclerosis (ALS) fueled and speeded up the research in C9orf72‐related ALS and FTD worldwide. 1,2 This pathogenic expansion could cause disease by loss of normal function of C9orf72 protein, RNA toxicity, and dipeptide‐repeat proteins aggregates. 3,4 Although the mechanisms for different phenotypes of C9orf72 HRE have not been well unveiled, the proteomic cerebrospinal fluid analyses and imaging studies provided potential biomarkers for C9orf72‐linked FTD and ALS. 5‐6 Previous studies showed the most common symptoms of C9orf72‐linked FTD were behavioral disinhibition and psychiatric disorders. 7‐9 Notably, 60% of C9orf72‐related FTD patients developed motor neuron disease symptoms during follow‐up. 9 C9orf72 HRE was the leading genetic cause of ALS and FTD in Caucasian populations, accounting for 21.7%‐47.0% in familial ALS, 13.8%‐48.1% in familial FTD, 4.1%‐21.1% in sporadic ALS, and 2.2%‐18.8% in sporadic FTD. 10,11 However, the C9orf72 HRE was rare in the Asian population, which could only explain around 0.4% ALS in Japan, 3.5% family ALS, and 0.5% sporadic ALS in Chinese populations. 12,13 The prevalence of C9orf72‐related FTD was not clear in China, which calls for a large‐scale multicenter study. The genetic investigation revealed more than 93 times repeat expansions (normal &lt;30) in C9orf72 (Figure 1C). [...]the patient exhibited limbs weakness, progressive muscular dystrophy, and dysphagia. Speech therapy may have some efficacy on language dysfunction. [...]antisense oligonucleotide target is considered a potential target for patients with C9orf72 HRE.</description><identifier>ISSN: 1755-5930</identifier><identifier>EISSN: 1755-5949</identifier><identifier>DOI: 10.1111/cns.13639</identifier><identifier>PMID: 33788382</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; Alzheimer's disease ; Amyloid beta-Peptides - cerebrospinal fluid ; Amyotrophic lateral sclerosis ; Antisense oligonucleotides ; Asians ; Atrophy ; C9orf72 Protein - genetics ; Cerebrospinal fluid ; Dementia ; Dementia disorders ; DNA Repeat Expansion - genetics ; Dysphagia ; Electromyography ; Family medical history ; Female ; Frontotemporal dementia ; Frontotemporal Dementia - genetics ; Humans ; Letter to the Editor ; Magnetic Resonance Imaging ; Mental disorders ; Motor neuron diseases ; Muscular dystrophy ; Patients ; Pedigree ; Peptide Fragments - cerebrospinal fluid ; Phenotypes ; Regulatory sequences ; tau Proteins - cerebrospinal fluid ; Toxicity</subject><ispartof>CNS neuroscience &amp; therapeutics, 2021-06, Vol.27 (6), p.725-727</ispartof><rights>2021 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4109-862cc4dad9af8e23f24b8a046f5555c701c1428d24a6ff6ba73cfc9f0507d5283</citedby><cites>FETCH-LOGICAL-c4109-862cc4dad9af8e23f24b8a046f5555c701c1428d24a6ff6ba73cfc9f0507d5283</cites><orcidid>0000-0003-2106-572X ; 0000-0002-2203-0046</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2524656787/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2524656787?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,44590,46052,46476,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33788382$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xue, Yan‐Yan</creatorcontrib><creatorcontrib>Wu, Zhi‐Ying</creatorcontrib><creatorcontrib>Li, Hong‐Fu</creatorcontrib><title>Identification of pathogenic C9orf72 hexanucleotide repeat expansion in a Chinese patient with frontotemporal dementia: A case report</title><title>CNS neuroscience &amp; therapeutics</title><addtitle>CNS Neurosci Ther</addtitle><description>The discovery that abnormal GGGGCC hexanucleotide repeat expansions (HRE) in C9orf72 was a common cause of FTD and amyotrophic lateral sclerosis (ALS) fueled and speeded up the research in C9orf72‐related ALS and FTD worldwide. 1,2 This pathogenic expansion could cause disease by loss of normal function of C9orf72 protein, RNA toxicity, and dipeptide‐repeat proteins aggregates. 3,4 Although the mechanisms for different phenotypes of C9orf72 HRE have not been well unveiled, the proteomic cerebrospinal fluid analyses and imaging studies provided potential biomarkers for C9orf72‐linked FTD and ALS. 5‐6 Previous studies showed the most common symptoms of C9orf72‐linked FTD were behavioral disinhibition and psychiatric disorders. 7‐9 Notably, 60% of C9orf72‐related FTD patients developed motor neuron disease symptoms during follow‐up. 9 C9orf72 HRE was the leading genetic cause of ALS and FTD in Caucasian populations, accounting for 21.7%‐47.0% in familial ALS, 13.8%‐48.1% in familial FTD, 4.1%‐21.1% in sporadic ALS, and 2.2%‐18.8% in sporadic FTD. 10,11 However, the C9orf72 HRE was rare in the Asian population, which could only explain around 0.4% ALS in Japan, 3.5% family ALS, and 0.5% sporadic ALS in Chinese populations. 12,13 The prevalence of C9orf72‐related FTD was not clear in China, which calls for a large‐scale multicenter study. The genetic investigation revealed more than 93 times repeat expansions (normal &lt;30) in C9orf72 (Figure 1C). [...]the patient exhibited limbs weakness, progressive muscular dystrophy, and dysphagia. Speech therapy may have some efficacy on language dysfunction. [...]antisense oligonucleotide target is considered a potential target for patients with C9orf72 HRE.</description><subject>Adult</subject><subject>Alzheimer's disease</subject><subject>Amyloid beta-Peptides - cerebrospinal fluid</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Antisense oligonucleotides</subject><subject>Asians</subject><subject>Atrophy</subject><subject>C9orf72 Protein - genetics</subject><subject>Cerebrospinal fluid</subject><subject>Dementia</subject><subject>Dementia disorders</subject><subject>DNA Repeat Expansion - genetics</subject><subject>Dysphagia</subject><subject>Electromyography</subject><subject>Family medical history</subject><subject>Female</subject><subject>Frontotemporal dementia</subject><subject>Frontotemporal Dementia - genetics</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Magnetic Resonance Imaging</subject><subject>Mental disorders</subject><subject>Motor neuron diseases</subject><subject>Muscular dystrophy</subject><subject>Patients</subject><subject>Pedigree</subject><subject>Peptide Fragments - cerebrospinal fluid</subject><subject>Phenotypes</subject><subject>Regulatory sequences</subject><subject>tau Proteins - cerebrospinal fluid</subject><subject>Toxicity</subject><issn>1755-5930</issn><issn>1755-5949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNp1kU1OHDEQhS0ECoRkwQUiS1llMeD2T7fNAgm1SIKEkgVkbXncZdpoxu7YngAH4N7xMGREFtSmSvKrr578EDpqyHFT68SGfNywlqkddNB0QsyE4mp3OzOyj97nfEdIS6WS79A-Y52UTNID9HQ5QCjeeWuKjwFHhydTxngLwVvcq5hcR_EIDyas7AJi8QPgBBOYguFhMiGvt3zABvejD5Bhve8rE9_7MmKXYiixwHKKySzwAMv1OXOKz7E1-RkVU_mA9pxZZPj40g_Rr68XN_332dXPb5f9-dXM8oaomWyptXwwgzJOAmWO8rk0hLdO1LIdaWzDqRwoN61z7dx0zDqrHBGkGwSV7BCdbbjTar6EwVYv1ZWekl-a9Kij8fr_l-BHfRv_aFm_mStRAZ9fACn-XkEu-i6uUqieNRWUt6LtZFdVXzYqm2LOCdz2QkP0OjFdE9PPiVXtp9eWtsp_EVXByUZw7xfw-DZJ9z-uN8i_4LWjeA</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Xue, Yan‐Yan</creator><creator>Wu, Zhi‐Ying</creator><creator>Li, Hong‐Fu</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2106-572X</orcidid><orcidid>https://orcid.org/0000-0002-2203-0046</orcidid></search><sort><creationdate>202106</creationdate><title>Identification of pathogenic C9orf72 hexanucleotide repeat expansion in a Chinese patient with frontotemporal dementia: A case report</title><author>Xue, Yan‐Yan ; Wu, Zhi‐Ying ; Li, Hong‐Fu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4109-862cc4dad9af8e23f24b8a046f5555c701c1428d24a6ff6ba73cfc9f0507d5283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Alzheimer's disease</topic><topic>Amyloid beta-Peptides - cerebrospinal fluid</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Antisense oligonucleotides</topic><topic>Asians</topic><topic>Atrophy</topic><topic>C9orf72 Protein - genetics</topic><topic>Cerebrospinal fluid</topic><topic>Dementia</topic><topic>Dementia disorders</topic><topic>DNA Repeat Expansion - genetics</topic><topic>Dysphagia</topic><topic>Electromyography</topic><topic>Family medical history</topic><topic>Female</topic><topic>Frontotemporal dementia</topic><topic>Frontotemporal Dementia - genetics</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Magnetic Resonance Imaging</topic><topic>Mental disorders</topic><topic>Motor neuron diseases</topic><topic>Muscular dystrophy</topic><topic>Patients</topic><topic>Pedigree</topic><topic>Peptide Fragments - cerebrospinal fluid</topic><topic>Phenotypes</topic><topic>Regulatory sequences</topic><topic>tau Proteins - cerebrospinal fluid</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xue, Yan‐Yan</creatorcontrib><creatorcontrib>Wu, Zhi‐Ying</creatorcontrib><creatorcontrib>Li, Hong‐Fu</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>CNS neuroscience &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xue, Yan‐Yan</au><au>Wu, Zhi‐Ying</au><au>Li, Hong‐Fu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of pathogenic C9orf72 hexanucleotide repeat expansion in a Chinese patient with frontotemporal dementia: A case report</atitle><jtitle>CNS neuroscience &amp; therapeutics</jtitle><addtitle>CNS Neurosci Ther</addtitle><date>2021-06</date><risdate>2021</risdate><volume>27</volume><issue>6</issue><spage>725</spage><epage>727</epage><pages>725-727</pages><issn>1755-5930</issn><eissn>1755-5949</eissn><abstract>The discovery that abnormal GGGGCC hexanucleotide repeat expansions (HRE) in C9orf72 was a common cause of FTD and amyotrophic lateral sclerosis (ALS) fueled and speeded up the research in C9orf72‐related ALS and FTD worldwide. 1,2 This pathogenic expansion could cause disease by loss of normal function of C9orf72 protein, RNA toxicity, and dipeptide‐repeat proteins aggregates. 3,4 Although the mechanisms for different phenotypes of C9orf72 HRE have not been well unveiled, the proteomic cerebrospinal fluid analyses and imaging studies provided potential biomarkers for C9orf72‐linked FTD and ALS. 5‐6 Previous studies showed the most common symptoms of C9orf72‐linked FTD were behavioral disinhibition and psychiatric disorders. 7‐9 Notably, 60% of C9orf72‐related FTD patients developed motor neuron disease symptoms during follow‐up. 9 C9orf72 HRE was the leading genetic cause of ALS and FTD in Caucasian populations, accounting for 21.7%‐47.0% in familial ALS, 13.8%‐48.1% in familial FTD, 4.1%‐21.1% in sporadic ALS, and 2.2%‐18.8% in sporadic FTD. 10,11 However, the C9orf72 HRE was rare in the Asian population, which could only explain around 0.4% ALS in Japan, 3.5% family ALS, and 0.5% sporadic ALS in Chinese populations. 12,13 The prevalence of C9orf72‐related FTD was not clear in China, which calls for a large‐scale multicenter study. The genetic investigation revealed more than 93 times repeat expansions (normal &lt;30) in C9orf72 (Figure 1C). [...]the patient exhibited limbs weakness, progressive muscular dystrophy, and dysphagia. Speech therapy may have some efficacy on language dysfunction. [...]antisense oligonucleotide target is considered a potential target for patients with C9orf72 HRE.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>33788382</pmid><doi>10.1111/cns.13639</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-2106-572X</orcidid><orcidid>https://orcid.org/0000-0002-2203-0046</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1755-5930
ispartof CNS neuroscience & therapeutics, 2021-06, Vol.27 (6), p.725-727
issn 1755-5930
1755-5949
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8111495
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); Open Access: Wiley-Blackwell Open Access Journals; PubMed Central
subjects Adult
Alzheimer's disease
Amyloid beta-Peptides - cerebrospinal fluid
Amyotrophic lateral sclerosis
Antisense oligonucleotides
Asians
Atrophy
C9orf72 Protein - genetics
Cerebrospinal fluid
Dementia
Dementia disorders
DNA Repeat Expansion - genetics
Dysphagia
Electromyography
Family medical history
Female
Frontotemporal dementia
Frontotemporal Dementia - genetics
Humans
Letter to the Editor
Magnetic Resonance Imaging
Mental disorders
Motor neuron diseases
Muscular dystrophy
Patients
Pedigree
Peptide Fragments - cerebrospinal fluid
Phenotypes
Regulatory sequences
tau Proteins - cerebrospinal fluid
Toxicity
title Identification of pathogenic C9orf72 hexanucleotide repeat expansion in a Chinese patient with frontotemporal dementia: A case report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A59%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20pathogenic%20C9orf72%20hexanucleotide%20repeat%20expansion%20in%20a%20Chinese%20patient%20with%20frontotemporal%20dementia:%20A%20case%20report&rft.jtitle=CNS%20neuroscience%20&%20therapeutics&rft.au=Xue,%20Yan%E2%80%90Yan&rft.date=2021-06&rft.volume=27&rft.issue=6&rft.spage=725&rft.epage=727&rft.pages=725-727&rft.issn=1755-5930&rft.eissn=1755-5949&rft_id=info:doi/10.1111/cns.13639&rft_dat=%3Cproquest_pubme%3E2524656787%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4109-862cc4dad9af8e23f24b8a046f5555c701c1428d24a6ff6ba73cfc9f0507d5283%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2524656787&rft_id=info:pmid/33788382&rfr_iscdi=true